System Transmission

Top Signal

100#1 JOB

Activity

2168Ripe

+909 today

System

Live1m

Terminal Asset View

stockNASDAQ

APLM

$19.90+0.51%

Apollomics Inc - Class A

Ripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

76Ripe

Live Analysis Active

Company Mission

Apollomics develops cancer treatments that work by attacking tumors through multiple biological pathways simultaneously. Pharmaceutical companies and research institutions collaborate with them to advance these therapies through clinical trials. The company generates revenue through research partnerships and could earn money from future drug sales if treatments receive regulatory approval.

APL

Industry Context

Biotechnology companies develop medical treatments through scientific research. This industry is highly volatile because stock prices often move dramatically based on clinical trial results, regulatory approvals, and partnership announcements. Companies can spend years developing drugs before generating revenue from sales.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

89Matrix

Market Momentum

50.1— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.1x— Normal Volume

Today's Change

0.51%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Price energy is building quickly for a potential move. Bullish alignment confirmed.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing APLM across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 02:21 AM UTC

As-of 03-15-2026 02:06 UTC

Develops cancer drugs that target specific tumor types and makes money through partnerships with pharmaceutical companies and future drug sales.

Price dropped 2% from yesterday's close, suggesting short-term selling pressure as it trades below recent averages.

Biotech sector remains volatile with clinical trial results driving sentiment, watch for news on drug development progress, suggesting development.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...